Introduction
There is increasing evidence that degenerative processes in post mitotic cells can result from aberrant cell cycle activity triggered by a potent carcinogen (Feddersen et al., 1992; Heintz, 1993) . Because it is well established that c-myc can induce both programmed cell death and oncogenesis, depending on cell context (reviewed in Amati and Land, 1994; Packham and Cleveland, 1995; Ryan and Birnie, 1996) , we designed a study that would enable us to evaluate the eect of the overexpression of this oncogene on oligodendrocytes.
Oligodendrocytic gliomas are relatively rare in that they represent only 5 ± 15% of the gliomas diagnosed in humans (Russell and Rubinstein, 1989; Ganju et al., 1994) . Most neuroectodermal tumors in the mature human brain are of astrocytic origin and in anaplastic variants, such as glioblastoma multiforme, overexpression of the cellular oncogene c-myc is common (Trent et al., 1986) . The relatively low frequency of oligodendrocytic tumors indicates that oligodendrocytes are more resistant to neoplastic transformation than astrocytes. In the disseminated myelin disorder progressive multifocal leukoencephalopathy, which results from the infection of oligodendroglia by the oncogenic papovavirus JC, clinical symptoms appear to be related to the loss of myelin rather than the presence of glial tumors (Major et al., 1992; Berger and Concha, 1995) . To our knowledge, there has been only one report to date describing a relationship between the expression of the papovavirus large T antigen and the development of an oligo-astrocytoma and this involved a single immunocompetent patient (Rencic et al., 1996) . The incidence of tumors expressing markers speci®c to the oligodendrocyte lineage has been reported to be low in transgenic mice that expressed an activated c-neu oncogene, under control of the MBP promoter (Hayes et al., 1992) . In the 14 transgenic MBP/c-neu strains generated, a total of ®ve brain tumors were observed and these were con®ned to the progeny of four strains. The ultrastructural features of cells in the tumors were similar to those of poorly dierentiated cells and the light microscopic features of the tumors did not resemble those of human oligodendrogliomas. In contrast to the low frequency of oligodendrocytic tumors in MBP/c-neu transgenic mice, a high frequency of mammary adenocarcinomas was observed in transgenic mice that expressed the neu oncogene in mammary epithelium (Muller et al., 1988; Bouchard et al., 1989) .
Myelin is a laminar membraneous structure, laid down in segments around selected nerve ®bers, that increases the velocity of action potentials (reviewed in Raine, 1984; Pfeier et al., 1993; Morell et al., 1994; Bunge and Fernandez-Valle, 1995; Rosenbluth, 1995; Waxman and Black, 1995; Mirsky and Jessen, 1996; Ransom and Orkand, 1996) . The myelin of the central nervous system (CNS) is formed by post mitotic oligodendrocytes, which comprise a population of structurally heterogeneous cells found primarily in the white matter (reviewed in Szuchet, 1995) . In the corpus callosum and the optic nerve, a single oligodendrocyte typically myelinates between ®ve and 20 axonal internodes, whereas a one-to-one relationship is often observed in large axons of the spinal cord (Remahl and Hildebrand, 1990; Butt and Ransom, 1993) . A number of myelin-speci®c proteins are abundantly expressed by dierentiated oligodendrocytes and believed to participate in the formation of myelin (reviewed in Campagnoni, 1995) . The myelin basis protein (MBP) gene, for example, is expressed exclusively in myelinforming cells and is believed to be involved in the compaction of the myelin sheath. Using a transgenetic approach, in which a human c-myc oncogene was expressed under control of a 3 kb MBP promoter, we show in the present study that c-myc impairs the myelination of the CNS and that this is likely to be the consequence of a cytotoxic eect that destroys cells expressing the transgene. Our data also indicate that c-myc has little neoplastic potential in dierentiated oligodendroglia.
Results

Generation and characterization of MBP/c-myc transgenic mice
A total of ®ve transgenic mice that contained a human c-myc oncogene under transcriptional control of the MBP promoter were generated (Figure 1) . Two MBP/ c-myc F 0 transgenic mice, designated Tg2 and Tg3, developed severe action tremors around postnatal day 10 (P10) that progressed to tonic seizures within days. Tg2 was sacri®ced at P21 for electron microscopy. Tg3 died at P28, most likely as a consequence of seizures. A behaviorally normal F 0 mouse, designated Tg22, was most likely a germline mosaic in that only about 1/5 of its progeny were transgenic. All of the Tg22 transgenic ospring, however, developed action tremors and tonic seizures and died within 3 ± 5 weeks, making it impossible to establish a My22 transgenic strain. Two transgenic mice, Tg5 and Tg23, appeared behaviorally normal and transgenic strains, My5 and My23 respectively, were established from these founders. Intercrossing heterozygous transgenic mice from the My5 strain showed that 27% of the ospring (n=38) developed severe tremors and seizures and died within 3 ± 5 weeks. Similar experiments with heterozygous My23 mice revealed that only about 13% of the ospring (n=44) developed tremors and seizures and died prematurely.
Histochemical and electron microscopic analysis of spinal cord and optic nerve sections revealed that the CNS was severely hypomyelinated in aected transgenic mice (Figures 2b and 3b ). In parallel with the lack of central myelin in the c-myc mice, there was a marked reduction in mRNA encoding the major structural proteins of myelin, MBP and PLP ( Figure  4 ). In addition, we consistently detected only minor to moderately increased levels of c-myc gene expression in the brains of aected transgenic mice derived from distinct founders (Figure 4 ). Because concomitant low expression levels of c-myc and myelin speci®c mRNAs may re¯ect the possibility that high levels of c-myc are cytotoxic to oligodendroglia, we TUNEL stained (Gavrieli et al., 1992 ) saggital brain sections, to determine whether or not the rate of cell death in the CNS of MBP/c-myc transgenic mice was greater than that of age matched controls. In transgenic animals, the majority of TUNEL-labelled nuclei appeared as isolated single cells in regions that corresponded to white matter in normal animals (Figure 5a , b). At postnatal days 14 (P14) and P21, there were two to four times more TUNEL-labelled nuclei in the brains of transgenic animals than in the non-transgenic counterparts ( Figure 5c ). In addition, a twofold increase in the number of TUNEL-labeled cells was observed in aected transgenic mice at P14, but not at P21 ( Figure 5c ). To determine whether or not the The relevant structure of the c-myc gene, including the entire exon-intron area is illustrated at the top. The gene structure is presented in a 5' to 3' orientation, with exons shown as boxed regions; the translated regions are white and the untranslated regions are black. The transgene shown at the bottom of the ®gure contains exon 2 and 3 of the human c-myc gene¯anked at the 5' end by the mouse MBP promoter (3.1 kb). In order to insure high levels of expression of the transgene, exon 1, which contains negative regulatory elements, was removed (Xu et al., 1991) . The KpnI ± AatII fragment of MBP/c-myc was isolated from vector sequences and microinjected into fertilized mouse eggs to produce transgenic mice. Restriction sites are as follows: AatII, A; ClaI, C; KpnI, K; XbaI, X Figure 2 Sections through cervical levels of the spinal cord stained for myelin with Luxol Fast Blue from (a) a non-transgenic control showing darkly stained white matter tracts; (b) a shaking transgenic mouse of the same age, P21, showing a generalized hypomyelination majority of TUNEL stained cells in the CNS expressed c-myc, we double-stained sections with a human c-myc monoclonal antibody and the TUNEL technique. As shown in Figure 6 (white arrows), most of the TUNEL positive cells in the subcortical white matter of an aected P16 animal were c-myc positive. Only a few TUNEL positive cells appeared to be c-myc negative (indicated by white circles in Figure 6 ).
Glial cells, in various stages of degeneration, were occasionally observed in electron micrographs of optic nerve sections from c-myc transgenic mice, but were not observed in the CNS of age matched controls (Figure 3c ± f) . During the early stages of degeneration, the glial cell nuclei contained highly condensed chromatin and a disrupted nuclear membrane, while the cytoplasm and the cell membrane appeared normal (Figure 3c ). At more advanced stages, the cytoplasm of degenerating cells appeared loaded with pyknotic chromatin and lysosomal vacuoles (Figure 3d ). Small membranous spheroids were scattered around axons and some of these appeared to be in physical contact with outer mesaxon-like processes of degenerating Higher magni®cation electron micrograph of a degenerating glial cell (c) with highly condenced chromatin (n) and fragmented nuclear membrane. The surrounding cytoplasm and cell membrane appears normal. Note the beginning of chromatin dissemination in the cytoplasm (arrow). More pronounced stage of degeneration (d) showing dissemination of pyknotic chromatin (asterisk) and an autophagosome containing cellular debris (arrow). Early degradation pro®le of myelin (e). Note the continuity of the dilated outer mesaxon-like process (arrow) containing electron dense cellular debris (asterisk), with a degenerating myelin sheath (ax, axon). Heterophagy of cell remnants by an activated microglia (f) showing con®nement of electron dense material and chromatin (asterisk) by the cell membrane (arrow heads) and the nucleus (n) of the microglial cell. Scale bars, 2 mm (a, b); 1 mm (c, f); 0.5 mm (d); 0.2 mm (e) myelin (Figure 3e ). Microglia containing lysosomal vacuoles and chromatin debris were frequently observed in the optic nerve, indicating that heterophagy played an important role in removal of the degenerating cells (Figure 3f) .
A total of 32 unaected transgenic mice from the My5 and My23 strains were observed closely for 12 months for signs of behavioral abnormalities. Weak tail tremors were apparent in about 30% of the aged mice. Macroscopic examination of the brain and spinal cord of these animals at autopsy revealed no evidence of tumor pathology.
Discussion
Expression of the proto-oncogene c-myc has been linked to the development of both undierentiated and dierentiated glial cell tumors (Trent et al., 1986; LaRocca et al., 1989; MacGregor and Zi, 1990; Radner et al., 1993; Hirvonen et al., 1994; Chattopadhyay et al., 1995) . Oligo-astrocytomas (mixed gliomas) are brain tumors composed of a mixture of astrocytes and oligodendrocytes. Banerjee and collaborators examined the relationship between the expression of c-myc and proliferating cell nuclear antigen (PCNA) in low-grade and malignant mixed gliomas (Banerjee et al., 1996) . A positive correlation was demonstrated between PCNA expression and cell proliferation in both the astrocytic and the oligodendrocytic areas of malignant mixed gliomas, while a similar correlation between c-myc and cell proliferation was observed only in the astrocytic areas of the same tumors. A likely explanation for this phenomenon is that high levels of c-myc are cytotoxic to oligodendrocytic tumor cells. Orian et al. (1994) generated a total of nine transgenic strains of mice that harbored an activated c-myc oncogene under transcriptional control of a 1.3 kb MBP promoter. No brain tumors were reported in these mice, although a transient shivering phenotype, which correlated with a central myelin defect, occurred in the progeny from one strain, designated 2 ± 50. Because the authors were unable to detect c-myc gene expression in the 2 ± 50 transgenic mice, they concluded that hypomyelination in the 2 ± 50 strain was unrelated to c-myc expression that resulted from the insertion of the transgene into the 9F2-F4 chromosomal region. A likely alternative explanation for the absence of transgene expression in the 2 ± 50 strain is that threshold levels of c-myc trigger oligodendrocyte loss by programmed cell death.
In the present study, we used a 3 kb MBP promoter because it had previously been shown that the sequences contained within this promoter are sufficient to selectively produce high levels of transgene expression in myelin-forming cells (Jensen et al., 1993) . Three transgenic founders and transgenic progeny from two unaected F 0 transgenic mice developed similar clinical phenotypes, characterized by severe action tremors, tonic seizures and premature death. Aected MBP/c-myc mice died before 5 weeks of age, most probably as a consequence of seizures and the lack of myelin. Although transgenic mice harboring an oncogene that has been introduced are often predisposed to the development of a characteristic type of neoplasm, tumors in these animals generally arise stochastically because they require spontaneous mutations in genes that collaborate with the introduced oncogene (Adams and Cory, 1991) . The lifespan of the aected MBP/c-myc mice, was however, too short to investigate the oncogenic potential of c-myc in oligodendroglia. Therefore, heterozygous transgenic mice from strain My5 and My23 were followed for up to a year in order to determine whether or not gliomas appeared in these mice at older ages. Since these mice harbor a greater number of TUNELlabeled cells in white matter regions than nontransgenic controls, it was not surprising that a high proportion of the mice developed neurologic de®cits with age. Because there was no evidence of tumor pathology at autopsy in these animals, we believe that the tremors most likely resulted from the cytotoxic eect of c-myc rather than from neoplasm. This conclusion is strengthened by the observation that the hypomyelination observed in the MBP/c-myc transgenic mice at young ages also appears to be primarily a consequence of c-myc cytotoxicity. Action tremors in the transgenic mice were evident around P10 and became progressively more severe during the second and third postnatal weeks. The onset of the neurologic de®cits in these mice correlated with an increase in the number of TUNEL-labeled nuclei that were present primarily in white matter regions. At both P14 and P21, there was a greater number of TUNEL-labeled nuclei in the brains of both aected and unaected MBP/c-myc transgenic mice than there were in age matched controls. However, a signi®cant increase in the number of TUNEL-labeled cells in aected transgenic mice, as compared with age matched unaected transgenics, was only observed prior to P21. Because there is a high rate of myelin synthesis in mice during the second and third postnatal weeks and because MBP expression reaches its peak around P18 (Benjamins and Smith, 1984) , a behavioraly relevant cytotoxic loss of oligodendroglia most likely occurred during this time period in aected transgenic mice. This scenario is supported by the observations that aected transgenic animals were severely hypomyelinated at P21 and that the majority of TUNEL positive cells in P16 animals were also c-myc positive. Ultrastructural examination of optic nerves from transgenic mice revealed the presence of degenerating glial cells at various stages of disintegration, which were not observed in optic nerves from age-matched controls. The dismantling of these cells displayed many of the morphologic features of apoptosis including the condensation of the chromatin, dissolution of the nuclear membrane and heterophagy of cell remnants.
Taken together, our data suggest that deregulated expression of c-myc is cytotoxic to oligodendroglia and, presumably because of this cytotoxic eect, these specialized cells appear resistant to c-myc induced neoplasm. Deregulated c-myc does not block differentiation of oligodendrocyte progenitor cells in vitro (Barnett and Crouch, 1995) and, in view of these results, it appears that the c-myc transgene exerts its cytotoxic eect on dierentiated cells. However, we cannot de®nitively rule out the possibility that c-myc interferes with terminal dierentiation of oligodendroglia in vivo, and that the late precursors then undergo apoptosis because of the failure of terminal differentiation.
Materials and methods
DNA cloning, transgenic mice, blotting and PCR analyses
To construct the MBP/c-myc transgene, a KpnI ± XbaI fragment containing the 3 kb MBP promoter was inserted in the 5' orientation at the KpnI ± XbaI site of a genomic clone of the human c-myc gene (Dalla-Favera et al., 1982) . In order to insure high levels of expression of the c-myc transgene, exon 1, which contains negative regulatory elements, was removed (Xu et al., 1991) . A KpnI ± AatII fragment containing the MBP promoter and exon 2 and 3 of the c-myc gene was isolated from vector sequences, diluted to 6 ng/ml in distilled water, and microinjected into fertilized mouse eggs to produce transgenic mice as described previously (Jensen et al., 1993) .
Transgenic mice were identi®ed by slot blots, Southern blots, and PCR analysis of DNA samples taken from tail biopsis. For PCR analysis, the following program was used in the thermocycler: one cycle at 968C for 5 min; 30 cycles each at 968C for 30 s, 558C for 30 s and 748C for 3 min; one cycle at 748C for 8 min. The following primers were used. MBP promoter primer: sense-5'-GGG CCC CGC GCG TAA CTG TGC G-3'. c-myc primer: antisense-5'-CCT CCG CCT ACC CAA CAC CAC G. Primers to a mouse immunophilin gene muFKBP38 (KM Pedersen and NA Jensen, unpublished) were used as a positive control for the genomic DNA template: sense-5'-CGG ATG AAG ACA CTG GTC-3' and antisense-5'-CAT GAG CGG GAC ACT GAG-3'.
For Northern blotting, total brain RNA was extracted by the isothiocyanate method (Chirgwin et al., 1979) , electrophoresed in formaldehyde/agarose gels, blotted onto Hybond N (Amersham International) membranes, and hybridized with 32 P-labeled megaprime (Amersham International) probes.
Histology and electron microscopy
For electron microscopy, the animals were deeply anaesthetized with pentobarbital and transcardially perfused with a phosphate buered solution of 1% glutaraldehyde and 1% paraformaldehyde (pH 7.2). The perfused animals were immersed in the same ®xative for 2 ± 7 days. Tissue samples were post®xed in 1% osmium, dehydrated and embedded in Epon. Ultrathin sections were mounted on mesh grids and stained with uranyl acetate and lead citrate.
TUNEL labeling and immunohistochemistry
Mice were perfused intracardially with 1% paraformaldehyde. The brains were removed, embedded in OCT compound (Tissue Tek) and frozen with CO 2 gas. Sections (10 mm) were cut with a cryostat microtome and collected on glass slides. To detect cells with fragmented DNA, we used the TUNEL method (Gavrieli et al., 1992) . Tissue sections were air-dried and incubated with 3% H 2 O 2 for 5 min at room temperature (RT) to inactivate endogenous peroxidase. The sections were washed three times in Hanks buer, followed by a single wash in terminal deoxynucleotidyltransferase (TdT) buer (0.5 M cacodylate, pH 6.8, 1 mM C 0 Cl 2 , 0.5 mM DTT, 0.05% BSA, 0.15 M NaCl), and then incubated for 1 h at 378C in a moist chamber with 40 mM biotin-16-dUTP (Boehringer Mannheim) and 0.5 U TdT (Boehringer Mannheim) per ml in TdT buer. After several washes in Hanks buer, the sections were incubated for 1 h at 378C in Vectastain elite ABC peroxidase standard solution (Vector Laboratories), rinsed twice in Hanks buer, and stained for 10 ± 15 min at RT using the aminoethylcarbazole substrate kit for horseradish peroxidase (Vector Laboratories). The sections were counter stained with Mayer's hematoxylin and mounted with Aqua-Poly/Mount (Polysciences, Inc.).
For double immunohistochemistry and TUNEL labeling, tissue samples were removed from animals perfused with 1% paraformaldehyde and immersed in a 30% sucrose solution overnight at 48C. The samples were embedded in OCT compound (Tissue Tek) and frozen with CO 2 gas prior to cryostat sectioning. Tissue sections, approximately 20 mm thick, were collected on glass slides, washed in TdT buer and incubated for 1 h at 378C in a moist chamber with 40 mM uorescein-12-dUTP (Boehringer Mannheim) and 0.5 U TdT per ml TdT buer. After several washes in Hanks buer, the sections were incubated with the monoclonal anti human cmyc antibody mAG223 (1 : 100 dilution) for 1 h at 378C in a moist chamber. Following several washes in Hanks buer, the sections were then incubated with a rabbit anti mouse rhodamine conjugated antibody (DAKO, Denmark) (diluted 1 : 300) for 30 min at 378C in a moist chamber. The sections were extensively washed, mounted with Aqua-Poly/Mount and visualized with a Olympus BX50¯uorescent microscope. Photographs were taken under rhodamine and¯uorescein ®lters. The images were superimposed to identify the doublelabeled cells.
